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Abstract: We report the possible mechanism of development of cystoid macular edema (CME) 
in retinitis pigmentosa (RP) in the case of a 68-year-old woman with RP and CME in the right 
eye and resolving CME in the left eye. Spectral domain optical coherence tomography showed 
CME and posterior vitreoschisis in the nasal quadrant of the fundus without a posterior vitreous 
detachment (PVD). This vitreous pathology suggested bilateral thickening and shrinkage of the 
posterior vitreous cortex. In the right eye, CME was evident with no vitreofoveal separation. 
However, in the left eye, minimal change was seen in the CME associated with a focal shallow 
PVD over the fovea. The best-corrected visual acuity (BCVA) in the left eye increased to 0.3 
from 0.15 7 years after the first visit. Tangential vitreous traction on the macula may have caused 
the CME in the right eye. The shallow PVD over the fovea might have released the tangential 
vitreous traction from the fovea, induced spontaneous resolution of the CME, and improved 
the BCVA in the left eye.
Keywords: retinitis pigmentosa, cystoid macular edema, posterior vitreous detachment, posterior 
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Introduction
Cystoid macular edema (CME) is sometimes complicated by retinitis pigmentosa 
(RP) and may worsen visual acuity (VA) at a later stage.1,2 The prevalence of CME in 
patients with RP has been reported to be about 20% based on fluorescein angiography 
(FA) and fundus examination.3,4 Recent studies using time domain optical coherence 
tomography (OCT) have reported that OCT is more sensitive for detecting CME and 
atrophy in patients with RP than conventional ocular examinations, including FA and 
ophthalmoscopy.5,6 However, the pathogenesis of the development of CME in RP 
has not been clarified. CME develops in RP bilaterally and sometimes unilaterally. 
  However, advanced atrophic macular changes were found more frequently than 
CME in RP.4 Fishman et al speculated that macular cysts resulted from changes in the 
vitreomacular interface.3 The most recent generation of OCT, spectral domain OCT 
(SD-OCT), may detect the detailed changes in the vitreoretinal relationship. In the 
current report, we postulated a possible mechanism of the development of CME in a 
patient with RP by evaluating the vitreoretinal relationship using SD-OCT.
Case report
A 68-year-old woman was referred to us for evaluation of her RP. Typical fundus 
changes of the bone spicule intraretinal pigmentation in the mid-periphery and 
attenuated retinal vessels (Figure 1) and almost extinguished electroretinogram (ERG) Clinical Ophthalmology 2011:5 submit your manuscript | www.dovepress.com
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recordings of all responses by portable ERG (LE-3000®; 
Tomey Corporation, Nagoya, Japan), including single 
flash, cone, rod, and flicker (Figure 2), strongly supported 
the previous diagnosis of RP. Goldmann kinetic perimetry 
showed extensive bilateral visual field loss (Figure 3). Other 
family members had normal vision. The patient did not have 
a history of diabetes, uveitis, or ocular surgery. Her initial 
best-corrected visual acuity (BCVA) was 0.5 with +0.25 −0.5 
axis 75° in the right eye and 0.15 with +2.0 −1.5 axis 110° 
in the left eye. Slit-lamp biomicroscopy showed no evidence 
of a posterior vitreous detachment (PVD) or spindle-shaped 
vitreous opacities bilaterally. Seven years after the first visit, 
SD-OCT (CirrusTM HD OCT; Carl Zeiss Meditec, Dublin, 
CA) (Figure 4) showed CME and no evidence of PVD but 
posterior vitreoschisis in the nasal quadrant bilaterally. In the 
right eye (Figure 4A), CME was evident, and no vitreofoveal 
separation was observed. However, in the left eye (Figure 4B), 
minimal changes were seen in the CME associated with a 
focal shallow PVD over the fovea. The BCVA of her right eye 
was unchanged at 0.5, but the BCVA of her left eye improved 
to 0.3 from 0.15 at the first visit.
Discussion
The pathogenesis of CME associated with RP is uncertain. 
Some reports have suggested that retinal edema may be 
caused by inflammation resulting from degeneration of 
the outer retina.7,8 Other reports have suggested that some 
A B
Figure 1 Fundus appearance of the right A) and left B) eyes. The bone spicule 
deposits are clustered just anterior to the posterior pole. The cystoid macular 
edema is unremarkable in this photograph of both eyes. The white line indicates the 
optical coherence tomography scan line in Figure 4.
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Figure 2 The electroretinogram (ERG) of the current case compared with that of a normal eye. The patient has no ERG responses, including flash, cone, rod, and 30-Hz flicker.Clinical Ophthalmology 2011:5 submit your manuscript | www.dovepress.com
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changes in the vitreomacular interface may cause the 
macular pathology in patients with RP,3 and based on that 
hypothesis vitrectomy was performed to treat the CME.6 
CME can develop bilaterally and unilaterally. However, 
atrophic macular changes are seen frequently in RP. There 
seems to be no relationship between the development of 
CME and the RP stage or inheritance type. Although other 
coexisting factors such as diabetes, uveitis, or ophthalmic 
surgery may affect the pathogenesis of CME, it can develop 
in patients with RP without such risk factors. Therefore, focal 
  deterioration must affect the macula for CME to develop in 
RP. The current patient had no evidence of PVD bilaterally 
by biomicroscopy. SD-OCT also showed bilateral posterior 
vitreoschisis in the nasal quadrant of the fundus without a 
PVD. Posterior vitreoschisis is seen frequently in retinal vas-
cular diseases and results from strong vitreous adhesion to 
the retina and shrinkage of the vitreous.9 Bilateral CME was 
observed by SD-OCT, but the CME changes were minimal 
in the left eye. SD-OCT also showed a shallow focal PVD 
just over the fovea in the left eye. The BCVA improved to 0.3 
from 0.15 at the first visit. The shallow PVD over the fovea 
might have induced spontaneous resolution of CME and 
the improved BCVA in the left eye. In other words, strong 
tangential vitreous traction is a possible mechanism of the 
development of CME in the right eye.
Vitreous abnormalities have been well documented in all 
RP stages. In early-stage RP, dust-like particles were seen in 
the clear and solid vitreous. In the advanced stage, an atypical 
PVD progressed with formation of condensed irregular fiber 
aggregates.10 The morphologic vitreous changes in the current 
case, ie, no PVD without significant vitreous opacity, did not 
correspond well to the vitreous findings reported previously. 
However, posterior vitreoschisis may be the stage before the 
advanced stage that shows atypical PVD with formation of 
condensed irregular fiber aggregates. The atypical PVD found 
in the advanced stage may not be a true PVD but could be 
an advanced type of posterior vitreoschisis.
The current case suggested a new effective treatment 
option for CME in RP vitrectomy combined with internal 
limiting membrane (ILM) removal. Cases with RP have strong 
vitreous adhesion to the retina; therefore, simple vitrectomy 
A
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Figure 4 spectral domain optical coherence tomography images of the right A) and 
left B) eyes. In the right eye, cystoid macular edema (CMe) at the fovea and posterior 
vitreoschisis  (arrow)  in  the  nasal  quadrant  is  seen  without  a  posterior  vitreous 
detachment (PVD). In the left eye, minimal CMe at the fovea with a focal PVD 
(arrowhead) and posterior vitreoschisis (arrow) in the nasal quadrant are seen.
Figure 3 Goldmann kinetic perimetry indicates the marked constriction of the V-4 isopter and the inferior peripheral remaining visual field.Clinical Ophthalmology
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may be ineffective for releasing the tangential vitreous 
traction on the fovea. Numerous reports have discussed 
medical and surgical treatments. Some medical treatments, 
such as oral carbonic anhydrase inhibitor acetazolamide,11–13 
intravitreous triamcinolone,14 and antivascular endothelial 
growth factor agents,15 have been reported; however, most 
seem to only temporarily affect the CME. However, some 
studies have reported successful results with vitrectomy 
combined with ILM removal in some RP cases with CME.6,16 
The current case supports vitrectomy for treating CME in RP. 
However, cases with a shallow PVD over the fovea, even with 
extensive CME, should not undergo surgery, because there 
is a chance that the VA can recover in the future.
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